Analyst Recommendations
114.08 2.20(1.97%)10/04/2024
Neurocrine Biosciences, Inc. (NBIX)
Neurocrine Biosciences, Inc. (NBIX)
2024: Total Recommendations Consensus
To Grade | # of Recommendations |
---|---|
Overweight | 16 |
Buy | 10 |
Outperform | 7 |
Neutral | 4 |
Market Perform | 2 |
Sector Perform | 2 |
Equal-Weight | 1 |
5 records were shown. To view all data, Upgrade to PRO plan with only $1
Upgrades & Downgrades